These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9194505)

  • 1. Metabolic effects of long-term treatments with nifedipine-retard and captopril in young hypertensive patients.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Am J Hypertens; 1997 Jun; 10(6):600-10. PubMed ID: 9194505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension.
    Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
    Diabetes Res Clin Pract; 1992 May; 16(2):137-43. PubMed ID: 1600852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rational approach to selection of antihypertensive therapy in persons with metabolic syndrome: efficacy of monotherapy with spirapril and its combination with retard form of nifedipine].
    Mamedov MN; Kiseleva NV
    Kardiologiia; 2006; 46(9):26-30. PubMed ID: 17047619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics.
    Jasik M; Kasperska-Dworak A; Czyzyk A
    Diabetes Res Clin Pract; 1996 Jun; 33(1):59-66. PubMed ID: 8877277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of captopril and nifedipine in black and white patients with hypertensive crisis.
    Damasceno A; Ferreira B; Patel S; Sevene E; Polónia J
    J Hum Hypertens; 1997 Aug; 11(8):471-6. PubMed ID: 9322826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
    Giordano M; Castellino P; Solini A; Canessa ML; DeFronzo RA
    Metabolism; 1997 Nov; 46(11):1316-23. PubMed ID: 9361692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension.
    Ghiadoni L; Huang Y; Magagna A; Buralli S; Taddei S; Salvetti A
    J Hypertens; 2001 Mar; 19(3 Pt 2):547-51. PubMed ID: 11327628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term effects of captopril versus nifedipine retard on the lipid profile of mild to moderate normolipidemic essential hypertension patients. In representation of the Eastern Andalouz Cooperative Study].
    Aranda P; López S; Aranda FJ; Carmona JR; Frutos MA; López de Novales E
    Rev Clin Esp; 1993 Jun; 193(1):7-11. PubMed ID: 8337465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis.
    Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J
    Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension in obese patients with heart hypertrophy. Effects of captopril on insulin sensitivity and growth hormone].
    Velasco-Cornejo IF; Martin LC; Brandão-Neto J; Marchioli M; de Barros e Silva M; Anthanázio-Heliodoro Rde C; Franco RJ da S
    Arq Bras Cardiol; 1995 Feb; 64(2):125-32. PubMed ID: 7575157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
    Giordano M; Sanders LR; Castellino P; Canessa ML; DeFronzo RA
    Nephron; 1996; 72(3):447-53. PubMed ID: 8852495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
    Jenkins DA; Cowan P; Patrick AW; Clarke BF
    Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
    Lin J; Chen D; Wu K
    Zhonghua Yi Xue Za Zhi; 1998 Mar; 78(3):200-2. PubMed ID: 10923530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hypotensive, natriuretic, and hormonal effects of nifedipine in salt-sensitive and salt-resistant black normotensive and hypertensive subjects.
    Damasceno A; Santos A; Pestana M; Serrão P; Caupers P; Soares-da-Silva P; Polónia J
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):346-53. PubMed ID: 10470991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertensive patients.
    Millgård J; Hägg A; Sarabi M; Lind L
    J Hum Hypertens; 1998 Aug; 12(8):511-6. PubMed ID: 9759984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).
    Galletti F; Strazzullo P; Capaldo B; Carretta R; Fabris F; Ferrara LA; Glorioso N; Semplicini A; Mancini M
    J Hypertens; 1999 Mar; 17(3):439-45. PubMed ID: 10100083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension.
    Maccario M; Oleandri SE; Avogadri E; Rossetto R; Grottoli S; Procopio M; Camanni F; Ghigo E
    J Endocrinol Invest; 1998 Jan; 21(1):56-63. PubMed ID: 9633024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril.
    Kusaka M; Atarashi K; Matsumoto K; Sumida Y; Matsuura H; Shingu T; Kajiyama G
    Am J Hypertens; 1991 Sep; 4(9):735-9. PubMed ID: 1930858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.